Stanley Laman Group Ltd. Has $334,000 Stock Holdings in Intuitive Surgical, Inc. $ISRG

Stanley Laman Group Ltd. trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 29.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 614 shares of the medical equipment provider’s stock after selling 254 shares during the quarter. Stanley Laman Group Ltd.’s holdings in Intuitive Surgical were worth $334,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of ISRG. Chilton Capital Management LLC increased its holdings in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical in the first quarter valued at about $26,000. LFA Lugano Financial Advisors SA bought a new position in shares of Intuitive Surgical during the first quarter worth about $30,000. TD Capital Management LLC raised its position in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the last quarter. Finally, 1248 Management LLC acquired a new position in shares of Intuitive Surgical in the first quarter worth approximately $30,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 2.6%

NASDAQ:ISRG opened at $446.13 on Friday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock has a market capitalization of $159.93 billion, a price-to-earnings ratio of 62.22, a PEG ratio of 4.69 and a beta of 1.61. The firm has a fifty day simple moving average of $454.97 and a two-hundred day simple moving average of $495.75.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s revenue was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.78 EPS. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have weighed in on ISRG shares. Royal Bank Of Canada reissued an “outperform” rating and set a $615.00 target price on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday, October 8th. Piper Sandler reiterated an “overweight” rating and set a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, The Goldman Sachs Group lowered their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research report on Wednesday, October 1st. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $580.29.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares of the company’s stock, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.